Pressure grows on ministers to end secrecy over UK medicines deal with Trump

As part of the deal, the government has committed to doubling the UK’s spend on new drugs from 0.3% of GDP to 0.6% by 2035, which will entail continued increases in spending between now and then. Photograph: Yves Herman/Reuters

Ministers are under growing pressure to end the “secrecy” around the UK’s deal with the US over the cost of medicines, which critics claim is “a Trump shakedown of the NHS”.

MPs from Labour and several opposition parties want the government to publish its impact assessment of the agreement it reached last month with Donald Trump’s administration.